Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Oral contraceptives and risk of familial breast cancer.

Cancer detection and prevention - 1 Jan 2002

Heimdal Ketil, Skovlund Eva, Møller Pål

Abstract excerpt

The risk of breast cancer of oral contraceptive (OC) use in 1423 women from families with hereditary/familial breast cancer recruited through a cancer family clinic was analyzed in a matched case-control study. Ninety-eight women tested positive for a BRCA1 mutation. Hazard ratio for ever use of OCs adjusted for other risk factors was 0.90 (95% confidence interval (CI) 0.68-1.18) in the total data set and 2.00...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Case-Control Studies
Share to Confidence Intervals

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Contraceptives, Oral

Share to Genes, BRCA1

Share to Norway

Share to Population Surveillance

Share to Time Factors

Source

Identifiers

PMID: 12088199
DOI: 10.1016/s0361-090x(02)00004-1

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Oral contraceptives and risk of familial breast cancer.PMID 12088199Read ↗

Oral contraceptives and family history of breast cancer.Semantic proximity Read ↗

Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in BRCA1 and BRCA2.Semantic proximity Read ↗

Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group.Semantic proximity Read ↗

Oral contraceptive use and BRCA penetrance: a case-only study.Semantic proximity Read ↗

BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50.Semantic proximity Read ↗

Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer.Semantic proximity Read ↗

Oral contraceptives and risk of breast cancer and ovarian cancer in women with a BRCA1 or BRCA2 mutation: a meta-analysis of observational studies.Semantic proximity Read ↗

Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: a meta-analysis.Semantic proximity Read ↗

Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers.Semantic proximity Read ↗

The role of oral contraception use in the occurrence of breast cancer. A retrospective study of 405 patients.Semantic proximity Read ↗

Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.